chr18-662209-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001071.4(TYMS):c.343C>T(p.Arg115Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000616 in 1,461,636 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )
Consequence
TYMS
NM_001071.4 stop_gained
NM_001071.4 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 3.79
Genes affected
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 18-662209-C-T is Pathogenic according to our data. Variant chr18-662209-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 1693535.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr18-662209-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYMS | NM_001071.4 | c.343C>T | p.Arg115Ter | stop_gained | 3/7 | ENST00000323274.15 | NP_001062.1 | |
TYMS | NM_001354867.2 | c.343C>T | p.Arg115Ter | stop_gained | 3/6 | NP_001341796.1 | ||
TYMS | NM_001354868.2 | c.205+4262C>T | intron_variant | NP_001341797.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYMS | ENST00000323274.15 | c.343C>T | p.Arg115Ter | stop_gained | 3/7 | 1 | NM_001071.4 | ENSP00000315644 | P1 | |
TYMS | ENST00000323224.7 | c.343C>T | p.Arg115Ter | stop_gained | 3/6 | 1 | ENSP00000314727 | |||
TYMS | ENST00000323250.9 | c.205+4262C>T | intron_variant | 1 | ENSP00000314902 | |||||
TYMS | ENST00000579128.1 | n.421C>T | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461636Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727130
GnomAD4 exome
AF:
AC:
9
AN:
1461636
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
727130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Dyskeratosis congenita, digenic Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 22, 2022 | - - |
Dyskeratosis congenita Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Bone Marrow Failure laboratory, Queen Mary University London | Jun 22, 2022 | This heterozygous nonsense variant of TYMS was identified in a 3-year old male with dyskeratosis congenita. The following ACMG/AMP criteria were used: PVS1, PM2_supporting, PP3 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;A;D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at